146 related articles for article (PubMed ID: 34164159)
41. Association of plasma homocysteine level with vaso-occlusive crisis in sickle cell anemia patients of Odisha, India.
Meher S; Patel S; Das K; Dehury S; Jit BP; Maske MM; Das P; Dash BP; Mohanty PK
Ann Hematol; 2019 Oct; 98(10):2257-2265. PubMed ID: 31440871
[TBL] [Abstract][Full Text] [Related]
42. Relevance of fibrinolytic protein (D-dimer) and fibrinopeptide A as markers of sickle cell anaemia vaso-occlusive crisis.
Ekwere TA; Ebele U; Ekanem M; Ogunro PS
Niger Postgrad Med J; 2014 Sep; 21(3):225-30. PubMed ID: 25331238
[TBL] [Abstract][Full Text] [Related]
43. Interleukin-27 and interleukin-37 are elevated in sickle cell anemia patients and inhibit in vitro secretion of interleukin-8 in neutrophils and monocytes.
Alagbe AE; Justo Junior AS; Ruas LP; Tonassé WV; Santana RM; Batista THC; Domingos IF; Araujo AS; Bezerra MAC; Santos MNN; Blotta MHSL
Cytokine; 2018 Jul; 107():85-92. PubMed ID: 29221667
[TBL] [Abstract][Full Text] [Related]
44. Testicular Volume in Children with Sickle Cell Anaemia in Uyo, a South-South Nigerian City.
Okorie OO; Eyong ME; Ekrikpo UE; Ekanem EE
J Trop Pediatr; 2021 Aug; 67(4):. PubMed ID: 34561714
[TBL] [Abstract][Full Text] [Related]
45. Nutritional status, hospitalization and mortality among patients with sickle cell anemia in Tanzania.
Cox SE; Makani J; Fulford AJ; Komba AN; Soka D; Williams TN; Newton CR; Marsh K; Prentice AM
Haematologica; 2011 Jul; 96(7):948-53. PubMed ID: 21459787
[TBL] [Abstract][Full Text] [Related]
46. Comparative study of clinical presentation and hematological indices in hospitalized sickle cell patients with severe Plasmodium falciparum malaria.
Purohit P; Mohanty PK; Patel S; Das P; Panigrahi J; Das K
J Infect Public Health; 2018; 11(3):321-325. PubMed ID: 28927555
[TBL] [Abstract][Full Text] [Related]
47. Effects of alpha-thalassemia-2 on the developmental changes of hematological values in children with sickle cell disease from Georgia.
Felice AE; McKie KM; Cleek MP; Marino EM; Kutlar A; McKie VC
Am J Hematol; 1987 Aug; 25(4):389-400. PubMed ID: 2441597
[TBL] [Abstract][Full Text] [Related]
48. Sickle cell disease: A distinction of two most frequent genotypes (HbSS and HbSC).
da Guarda CC; Yahouédéhou SCMA; Santiago RP; Neres JSDS; Fernandes CFL; Aleluia MM; Figueiredo CVB; Fiuza LM; Carvalho SP; Oliveira RM; Fonseca CA; Ndidi US; Nascimento VML; Rocha LC; Goncalves MS
PLoS One; 2020; 15(1):e0228399. PubMed ID: 31995624
[TBL] [Abstract][Full Text] [Related]
49. Wasting and stunting are still prevalent in children with sickle cell anaemia in Lagos, Nigeria.
Esezobor CI; Akintan P; Akinsulie A; Temiye E; Adeyemo T
Ital J Pediatr; 2016 May; 42(1):45. PubMed ID: 27146866
[TBL] [Abstract][Full Text] [Related]
50. Erythrocyte indices in Pre-school Nigerian Children with Sickle Cell Anaemia in Steady State.
Akodu SO; Njokanma OF; AdeoluKehinde O
Int J Hematol Oncol Stem Cell Res; 2015 Jan; 9(1):5-9. PubMed ID: 25802694
[TBL] [Abstract][Full Text] [Related]
51. Effectiveness of intermittent iron treatment of two- to six-year-old Jordanian children with iron-deficiency anemia.
Faqih AM; Kakish SB; Izzat M
Food Nutr Bull; 2006 Sep; 27(3):220-7. PubMed ID: 17542112
[TBL] [Abstract][Full Text] [Related]
52. Serum levels of copeptin, C-reactive protein and cortisol in different severity groups of sickle cell anaemia.
Akinlade KS; Atere AD; Rahamon SK; Olaniyi JA
Niger J Physiol Sci; 2013 Dec; 28(2):159-64. PubMed ID: 24937391
[TBL] [Abstract][Full Text] [Related]
53. Relationship between foetal haemoglobin and haematological indices in children with sickle cell anaemia from South Western Nigeria.
Akinlosotu MA; Adegoke SA; Oseni SB; Adeodu OO
Niger Postgrad Med J; 2017; 24(4):195-200. PubMed ID: 29355156
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of Foetal Haemoglobin Status among Nigerian Patients with Sickle Cell Anaemia Using High Performance Liquid Chromatography.
Ugwu NI; Nna EO; Ugwu CN; Ogah OE; Okike C; Ikeagwulonu RC; Nnadozie UU; Madu AJ; Okoye HC; Uzoma IC; Alo C; Ugwu GC; Ekpeagu VN; Okeke UI
West Afr J Med; 2021 Mar; 38(3):222-227. PubMed ID: 33765368
[TBL] [Abstract][Full Text] [Related]
55. Rheological properties of sickle erythrocytes in patients with sickle-cell anemia: The effect of hydroxyurea, fetal hemoglobin, and α-thalassemia.
Ballas SK; Connes P;
Eur J Haematol; 2018 Dec; 101(6):798-803. PubMed ID: 30204261
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of pharmacological efficacy and safety of hydroxyurea in sickle cell disease: Study of a pediatric cohort from Chhattisgarh, India.
Lad H; Naskar S; Punyasri Pasupuleti SKDB; Nahrel R; Sihare P; Chandak GR; Patra PK
Pediatr Hematol Oncol; 2023 May; 40(4):395-406. PubMed ID: 36226857
[TBL] [Abstract][Full Text] [Related]
57. Intermittent or uneven daily administration of low-dose hydroxyurea is effective in treating children with sickle cell anemia in Angola.
Chambers TM; Kahan S; Camanda JF; Scheurer M; Airewele GE
Pediatr Blood Cancer; 2018 Dec; 65(12):e27365. PubMed ID: 30051651
[TBL] [Abstract][Full Text] [Related]
58. Relationships between systemic vascular resistance, blood rheology and nitric oxide in children with sickle cell anemia or sickle cell-hemoglobin C disease.
Lamarre Y; Hardy-Dessources MD; Romana M; Lalanne-Mistrih ML; Waltz X; Petras M; Doumdo L; Blanchet-Deverly A; Martino J; Tressières B; Maillard F; Tarer V; Etienne-Julan M; Connes P
Clin Hemorheol Microcirc; 2014; 58(2):307-16. PubMed ID: 23302597
[TBL] [Abstract][Full Text] [Related]
59. Comparative study of the growth and nutritional status of Brazilian and Nigerian school-aged children with sickle cell disease.
Adegoke SA; Figueiredo MS; Adekile AD; Braga JAP
Int Health; 2017 Nov; 9(6):327-334. PubMed ID: 29036551
[TBL] [Abstract][Full Text] [Related]
60. Natural coagulation inhibitors (protein C, protein S, antithrombin) in patients with sickle cell anemia in a steady state.
Bayazit AK; Kilinç Y
Pediatr Int; 2001 Dec; 43(6):592-6. PubMed ID: 11737735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
